205 related articles for article (PubMed ID: 2818683)
1. Strategic considerations for the biotechnology business to the year 2000.
Cometta S
Arzneimittelforschung; 1989 Aug; 39(8):929-34. PubMed ID: 2818683
[TBL] [Abstract][Full Text] [Related]
2. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
[No Abstract] [Full Text] [Related]
3. Innovation drives success in Switzerland's biotech scene.
Whyte B
Drug Discov Today; 2005 Oct; 10(20):1342-5. PubMed ID: 16253869
[No Abstract] [Full Text] [Related]
4. Megatrends 2000: strategic implications for health care.
Coile RC
Hosp Strategy Rep; 1990 Jul; 2(9):1, 3-8. PubMed ID: 10170570
[No Abstract] [Full Text] [Related]
5. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
Persidis A; Persidis A
Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
[No Abstract] [Full Text] [Related]
6. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
Evens RP; Kaitin KI
Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
[TBL] [Abstract][Full Text] [Related]
7. The Indian and Chinese health biotechnology industries: potential champions of global health?
Frew SE; Kettler HE; Singer PA
Health Aff (Millwood); 2008; 27(4):1029-41. PubMed ID: 18607038
[TBL] [Abstract][Full Text] [Related]
8. Early-stage returns?
Booth BL
Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
[TBL] [Abstract][Full Text] [Related]
9. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice.
Piascik P
Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234
[TBL] [Abstract][Full Text] [Related]
10. Fresh horizons South Korea.
Cyranoski D
Nature; 2002 Dec; 420(6916):4-5. PubMed ID: 12478244
[No Abstract] [Full Text] [Related]
11. Biotechnology in India.
Ghosh PK
Australas Biotechnol; 1993; 3(4):214-5, 218-22. PubMed ID: 7764132
[TBL] [Abstract][Full Text] [Related]
12. Strategic alliances and market risk.
Havenaar M; Hiscocks P
Drug Discov Today; 2012 Aug; 17(15-16):824-7. PubMed ID: 22484547
[TBL] [Abstract][Full Text] [Related]
13. Medical entrepreneurism: the current opportunity in America.
Lexa FJ
J Am Coll Radiol; 2004 Oct; 1(10):762-8. PubMed ID: 17411697
[TBL] [Abstract][Full Text] [Related]
14. The evolution of biotechnology and its impact on health care.
Evens R; Kaitin K
Health Aff (Millwood); 2015 Feb; 34(2):210-9. PubMed ID: 25646100
[TBL] [Abstract][Full Text] [Related]
15. The further evolution of biotech.
Nagle T; Berg C; Nassr R; Pang K
Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
[TBL] [Abstract][Full Text] [Related]
16. Biotechnology and bioeconomy in China.
Li Q; Zhao Q; Hu Y; Wang H
Biotechnol J; 2006 Nov; 1(11):1205-14. PubMed ID: 17109491
[TBL] [Abstract][Full Text] [Related]
17. Hans Küpper discusses science and venture capital.
Küpper H
Drug Discov Today; 2004 Nov; 9(21):909-12. PubMed ID: 15501722
[TBL] [Abstract][Full Text] [Related]
18. [Strathmann AG: first OTC, now biotechnology. AIDS vaccines from German biotechnology research? (interview by Dr. med. Dirk Einecke)].
Strathmann G
MMW Fortschr Med; 2001 Oct; 143(42):58-9. PubMed ID: 11697293
[No Abstract] [Full Text] [Related]
19. Spin-offs versus start-ups as business models in biotechnology.
Persidis A; De Rubertis F
Nat Biotechnol; 2000 May; 18(5):570-1. PubMed ID: 10802637
[No Abstract] [Full Text] [Related]
20. Biotech business Down Under.
Beckley C
Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
[No Abstract] [Full Text] [Related]
[Next] [New Search]
